Ticker	Volume	Price	Price Delta
DJIA	12,580.70	+125.86	1.01%
S&P 500	1,332.42	+14.60	1.11%
Nasdaq	2,870.99	+33.46	1.18%

Ticker	Volume	Price	Price Delta
STOXX 50	2,160.31	+12.39	0.58%
FTSE 100	5,391.14	+34.80	0.65%
DAX	6,396.84	+73.65	1.16%

Ticker	Volume	Price	Price Delta
Nikkei	8,571.90	-85.18	-0.98%
TOPIX	718.22	-8.81	-1.21%
Hang Seng	18,663.70	-391.81	-2.06%

Gold

1,549.70

-0.08%

EUR-USD

1.2466

-0.2921%

Nasdaq

2,870.99

+1.18%

DJIA

12,580.70

+1.01%

S&P 500

1,332.42

+1.11%

FTSE 100

5,391.14

+0.65%

STOXX 50

2,160.31

+0.58%

DAX

6,396.84

+1.16%

Oil (WTI)

90.41

-0.39%

U.S. 10-year

1.721%

-0.019

BAC:US

7.44

+4.06%

FB:US

28.84

-9.62%

Bloomberg

Exchange: -
Sector: Consumer, Non-cyclical
Industry: Pharmaceuticals
Sub-Industry: Medical-Drugs

King Pharmaceuticals Inc

KG:US

Acquired

King Pharmaceuticals Inc (KG:US) was acquired by PFE:US

Company Profile

King Pharmaceuticals Incorporated manufactures, markets, and sells primarily branded prescription pharmaceutical products. The Company markets its pharmaceutical products to general and family practitioners, internal medicine physicians, and hospitals across the United States. King also provides contract manufacturing for a number of pharmaceutical and biotechnology companies.